Avanos Medical (AVNS) FCF Margin (2013 - 2026)
Avanos Medical (AVNS) reported FCF Margin of 9.11% for Q1 2026, down 2045.0% on a YoY basis from 0.47% in Q1 2025, and down 132.13% sequentially from 28.36% in Q4 2025.
Avanos Medical (AVNS) FCF Margin (2013 - 2026) Analysis & Trends
Avanos Medical (AVNS) has 14 years of FCF Margin data on file, last reported at 9.11% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 2045.0% year-over-year to 9.11%; the trailing twelve-month figure through Mar 2026 stood at 5.24% (down 1307.0% YoY), and the FY2025 full-year result was 10.42%, down 340.0% from the prior year.
- FCF Margin declined to 9.11% in Q1 2026, from 28.36% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 36.36% in Q4 2024 to a low of 9.11% in Q1 2026.
- A 5-year average of 8.42% and a median of 11.34% in 2025 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin sank 10806 bps in 2022 and surged 3243 bps in 2024, its largest moves.
- Tracing AVNS's FCF Margin over 5 years: stood at 24.34% in 2022, then sank by 84 bps to 3.92% in 2023, then jumped by 827 bps to 36.36% in 2024, then fell by 22 bps to 28.36% in 2025, then sank by 132 bps to 9.11% in 2026.
- Business Quant data shows AVNS's FCF Margin at 9.11% in Q1 2026, 28.36% in Q4 2025, and 3.94% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn | -9.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.11% |
| Dec 31, 2025 | 28.36% |
| Sep 30, 2025 | 3.94% |
| Jun 30, 2025 | -2.40% |
| Mar 31, 2025 | 11.34% |
| Dec 31, 2024 | 36.36% |
| Sep 30, 2024 | 11.74% |
| Jun 30, 2024 | 12.75% |
| Mar 31, 2024 | -7.28% |
| Dec 31, 2023 | 3.92% |
| Sep 30, 2023 | 14.71% |
| Jun 30, 2023 | -3.90% |
| Mar 31, 2023 | -6.78% |
| Dec 31, 2022 | 24.34% |
| Sep 30, 2022 | 13.41% |
| Jun 30, 2022 | 13.40% |
| Mar 31, 2022 | -1.62% |
| Dec 31, 2021 | 132.40% |
| Sep 30, 2021 | 9.99% |
| Jun 30, 2021 | 5.10% |